abt-199 and Anemia

abt-199 has been researched along with Anemia* in 2 studies

Reviews

1 review(s) available for abt-199 and Anemia

Article	Year
Novel therapies in low- and high-risk myelodysplastic syndrome. Expert review of hematology, 2019, Volume: 12, Issue:10 Topics: Activin Receptors, Type II; Anemia; Antineoplastic Agents; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Decitabine; Erythrocyte Transfusion; Hematinics; Humans; Immunoglobulin Fc Fragments; Iron Chelating Agents; Lenalidomide; Myelodysplastic Syndromes; Oligonucleotides; Prognosis; Recombinant Fusion Proteins; Risk Assessment; Stem Cell Transplantation; Sulfonamides; Thalidomide; Thrombopoietin; Transplantation, Homologous	2019

Article

Year

Novel therapies in low- and high-risk myelodysplastic syndrome.

Expert review of hematology, 2019, Volume: 12, Issue:10

Topics: Activin Receptors, Type II; Anemia; Antineoplastic Agents; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Decitabine; Erythrocyte Transfusion; Hematinics; Humans; Immunoglobulin Fc Fragments; Iron Chelating Agents; Lenalidomide; Myelodysplastic Syndromes; Oligonucleotides; Prognosis; Recombinant Fusion Proteins; Risk Assessment; Stem Cell Transplantation; Sulfonamides; Thalidomide; Thrombopoietin; Transplantation, Homologous

2019

Other Studies

1 other study(ies) available for abt-199 and Anemia

Article	Year
Anaemia during venetoclax ramp-up phase: Do not forget unusual causes. International journal of laboratory hematology, 2022, Volume: 44, Issue:5 Topics: Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Sulfonamides	2022